TRCT
COYA icon

Tower Research Capital (TRC)’s Coya Therapeutics COYA Stock Holding History

Tower Research Capital (TRC)’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.66K Buy
+1,182
New +$5.53K ﹤0.01% 4176
2025
Q4 		– Sell
-988
Closed -$5.63K – 5211
2025
Q3 		$5.63K Buy
988
+354
+56% +$2.15K ﹤0.01% 4218
2025
Q2 		$3.65K Buy
634
+349
+122% +$2.02K ﹤0.01% 4457
2025
Q1 		$1.84K Sell
285
-4,967
-95% -$31.4K ﹤0.01% 4638
2024
Q4 		$30.1K Buy
5,252
+4,777
+1,006% +$32.5K ﹤0.01% 2901
2024
Q3 		$3.06K Sell
475
-2,212
-82% -$14K ﹤0.01% 4900
2024
Q2 		$16.3K Buy
+2,687
New +$21.6K ﹤0.01% 3867
2024
Q1 		– Sell
-3,344
Closed -$24.8K – 5886
2023
Q4 		$24.8K Buy
3,344
+1,243
+59% +$6.9K ﹤0.01% 3525
2023
Q3 		$8.07K Buy
+2,101
New +$8.36K ﹤0.01% 4398

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Tower Research Capital (TRC)'s COYA Position: Q1 2026 in Review

Tower Research Capital (TRC) opened a new position in Coya Therapeutics (COYA) in Q1 2026: 1,182 shares worth $4.66K. The stake represents ﹤0.01% of the portfolio and ranks #4176 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in COYA as recently as Q3 2025.

Tower Research Capital (TRC) first reported a position in COYA in Q3 2023 and has held it in 9 quarters since. The position peaked at $30.1K in Q4 2024. 56 funds tracked by Wall St. Rank hold COYA as of Q1 2026.

  • Tower Research Capital (TRC) held 1,182 shares of Coya Therapeutics worth $4.66K as of Q1 2026.
  • Coya Therapeutics was a new Tower Research Capital (TRC) position in Q1 2026.
  • Coya Therapeutics made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4176 holding.
  • Tower Research Capital (TRC) first reported a position in Coya Therapeutics in Q3 2023 and has held it in 9 quarters since.
  • Tower Research Capital (TRC)'s Coya Therapeutics position peaked at $30.1K in Q4 2024.
  • 56 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.